GUJARAT THEMIS BIOSYN
Back to Balance Sheet
|
GUJARAT THEMIS BIOSYN Last 5 Year Total Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹318 Cr | ₹241 Cr | ₹187 Cr | ₹137 Cr | ₹98 Cr |
What is the latest Total Liabilities ratio of GUJARAT THEMIS BIOSYN ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹318 Cr |
| Mar2024 | ₹241 Cr |
| Mar2023 | ₹187 Cr |
| Mar2022 | ₹137 Cr |
| Mar2021 | ₹98 Cr |
How is Total Liabilities of GUJARAT THEMIS BIOSYN Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹318 Cr | 31.87 | |
| Mar2024 | ₹241 Cr | 29.13 | |
| Mar2023 | ₹187 Cr | 36.30 | |
| Mar2022 | ₹137 Cr | 39.37 | |
| Mar2021 | ₹98 Cr | - | |
Compare Total Liabilities of peers of GUJARAT THEMIS BIOSYN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GUJARAT THEMIS BIOSYN | ₹3,911.5 Cr | -0.5% | -9.3% | -3.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹477,312.0 Cr | 0.8% | 6.3% | 18.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹213,879.0 Cr | 8.6% | 20.7% | 18.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹194,094.0 Cr | 1.7% | 9.4% | 38.5% | Stock Analytics | |
| CIPLA | ₹118,992.0 Cr | 4.5% | 1.2% | -1.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,787.4 Cr | -0.3% | -14.8% | -9.5% | Stock Analytics | |
GUJARAT THEMIS BIOSYN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GUJARAT THEMIS BIOSYN | -0.5% |
-9.3% |
-3.1% |
| SENSEX | 2.7% |
1.5% |
-5.6% |
You may also like the below Video Courses